Executive summary As of May 31, 2022, there were 6· 9 million reported deaths and 17· 2
million estimated deaths from COVID-19, as reported by the Institute for Health Metrics and …

As the world navigates the coronavirus disease 2019 (COVID-19) pandemic, there is a
growing need to assess its impact in patients with autoimmune rheumatic diseases, such as …

The objectives of the study were to review the articles to identify (a) the epidemiology of
systemic lupus erythematosus (SLE) and coronavirus disease 2019 (COVID-19);(b) the …

Objective The aim was to explore the self-reported impact of the COVID-19 pandemic on
changes to care and behaviour in UK patients with systemic autoimmune rheumatic …

What is known and Objective Non‐clinical studies suggest that chloroquine (CQ) and
hydroxychloroquine (HCQ) have antiviral activities. Early clinical reports of successful HCQ …

Abstract Purpose of Review To summarize current knowledge of the impact of coronavirus
disease 19 (COVID-19) on patients with systemic lupus erythematosus (SLE). Recent …

Recent evidence reinforces the central role of HCQ in SLE therapy. The reduction in activity,
damage accrual and mortality is consistent across studies, countries and ethnical groups …

There is a growing interest in co-encapsulating multiple species to harness potential
synergy between them, enhance their stability and efficacy in various products. The aim of …

Background: During the coronavirus disease (COVID)-19 pandemic several drugs were
used to manage the patients mainly those with a severe phenotype. Potential drugs were …

Objectives During the COVID-19 pandemic, much communication occurred online, through
social media. This study aimed to provide patient perspective data on how the COVID-19 …